A Review of Antithrombotic Therapy for Transcatheter Aortic Valve Replacement

References

• . Stewart BF, Siscovick D, Lind BK, . Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–634
   PubMed Web of Science ®Google Scholar
• . Cosmi JE, Kort S, Tunick PA, . The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162(20):2345–2347
   PubMedGoogle Scholar
• . Rosenhek R, Klaar U, Schemper M, . Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J. 2004;25(3):199–205
   PubMed Web of Science ®Google Scholar
• . Braunwald E, Ross J. Aortic stenosis. Circulation. 1968;38( suppl 1):61–67
   PubMedGoogle Scholar
• . Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9( suppl E):57–64
   PubMed Web of Science ®Google Scholar
• . Vahanian A, Alfieri O, Andreotti F, ; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–2496
   PubMed Web of Science ®Google Scholar
• . Bonow RO, Carabello BA, Chatterjee K, ; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1–e142
   PubMed Web of Science ®Google Scholar
• . Cribier A, Eltchaninoff H, Bash A, . Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008
   PubMed Web of Science ®Google Scholar
• . Kodali S, Schwartz A. Transcatheter valve repair and replacement. Annu Rev Med. 2009;60:1–11
   PubMedGoogle Scholar
• . Edwards SAPIEN Transcatheter Heart Valve. Edwards Lifesciences Corporation, http://www.edwards.com/products/transcathetervalve/Pages/THVcategory.aspx. Accessed January 3, 2013
   Google Scholar
• . Core Valve® System. Medtronic, Inc. http://www.medtronic.com/corevalve/ous/system.html. Accessed January 3, 2013
   Google Scholar
• . Drews T, Pasic M, Buz S, . Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011;59(4):237–242
   PubMedGoogle Scholar
• . Denault B, Kirtane AJ, Kodali SK, . Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol. 2011;58(21):2143–2150
   PubMedGoogle Scholar
• . Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141( suppl 2):e576S–e600S
   PubMed Web of Science ®Google Scholar
• . Jneid H, Anderson JL, Wright RS, ; 2012 Writing Committee Members. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2012;126(7):875–910
   PubMed Web of Science ®Google Scholar
• . Holmes DR Jr, Mack MJ, Kaul S, . 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(13):1200–1254
   PubMed Web of Science ®Google Scholar
• . Bonow RO, Carabello BA, Chatterjee K, ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1–e148
   PubMedGoogle Scholar
• . Vahanian A, Alfieri O, Al—Attar N, . Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention. 2008;4(2):193–199
   PubMedGoogle Scholar
• . Levine GN, Bates ER, Blankenship JC, . 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–e651
   PubMed Web of Science ®Google Scholar
• . www.ClinicalTrials.gov. International, Multi-center, Open-label, Randomized Controlled Trial in Patients Undergoing TAVR to Determine the Treatment Effect (Both Safety and Efficacy) of Using Bivalirudin Instead of UFH. (BRAVO 2/3). NCT01651780. http://clinicaltrials.gov/ct2/show/NCT01651780?term=bivalirudin+TAVR&rank=1. Accessed January 3, 2013
   Google Scholar
• . Ussia GP, Scarabelli M, Mule M, . Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2011;108(12):1772–1776
   PubMed Web of Science ®Google Scholar
• . Grube E, Laborde JC, Gerckens U, . Percutaneous implantation of the Core Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114(15):1616–1624
   PubMedGoogle Scholar
• . Smith CR, Leon MB, Mack MJ, . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198
   PubMed Web of Science ®Google Scholar
• . Leon MB, Smith CR, Mack M, . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607
   PubMed Web of Science ®Google Scholar
• . Makkar RR, Fontana GP, Jilaihawi H, . Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696–1704
   PubMed Web of Science ®Google Scholar
• . Kodali SK, Williams MR, Smith CR. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686–1695
   PubMed Web of Science ®Google Scholar
• . www.ClinicalTrials.gov. Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: The ARTE Trial. NCT01559298. http://clinicaltrials.gov/ct2/show/NCT01559298?term=ARTE+trial&rank=1. Accessed January 3, 2013
   Google Scholar
• . www.ClinicalTrials.gov. Safety and Efficacy Study of the Medtronic Core Valve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement. NCT01240902. http://clinicaltrials.gov/ct2/show/NCT01240902?term=corevalve&rank=5. Accessed January 3, 2013
   Google Scholar
• . www.ClinicalTrials.gov. Safety and Efficacy Study of the Medtronic Core Valve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). NCT01586910. http://clinicaltrials.gov/ct2/show/NCT01586910?term=corevalve&rank=7. Accessed January 3, 2013
   Google Scholar
• . www.ClinicalTrials.gov. Transcatheter Versus Surgical Valve Implantation in Patients with Severe Aortic Valve Stenosis (TAVI vs SAVR). NCT01057173. http://clinicaltrials.gov/ct2/show/NCT01057173?term=corevalve&rank=13. Accessed January 3, 2013
   Google Scholar
• . www.ClinicalTrials.gov. A Comparison of Transcatheter Heart Valves in High Risk Patients with Severe Aortic Stenosis: The CHOICE Trial. NCT01645202. http://clinicaltrials.gov/ct2/show/NCT01645202?term=corevalve&rank=10. Accessed January 3, 2013
   Google Scholar
• . Kodali SK, O'Neill WW, Moses JW, . Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107(7):1058–1064
   PubMedGoogle Scholar
• . Walther T, Kasimir MT, Doss M, . One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg. 2011;39(4):532–537
   PubMedGoogle Scholar
• . Lefevre T, Kappetein AP, Wolner E, . One year follow-up of the mutli-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32(2):148–157
   PubMedGoogle Scholar
• . Thomas M, Schymik G, Walther T, . Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122(1):62–69
   PubMed Web of Science ®Google Scholar
• . Rodes—Cabau J, Webb JG, Cheung A, . Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55(11):1080–1090
   PubMed Web of Science ®Google Scholar
• . Grube E, Buellesfeld L, Mueller R, . Progress and current status of percutaneous aortic valve replacement: results of three device generations of the Core Valve ReValving System. Circ Cardiovasc Interv. 2008;1(3):167–175
   PubMed Web of Science ®Google Scholar
• . Avanzas P, Munoz—Garcia AJ, Segura J, . Percutaneous implantation of the Core Valve® self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. Rev Esp Cardiol. 2010;63(2):141–148
   PubMedGoogle Scholar
• . Petronio AS, De Carlo M, Bedogni F, . Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the Core Valve ReValving System. Circ Cardiovasc Interv. 2010;3(4):359–366
   PubMedGoogle Scholar
• . Piazza N, Grube E, Gerckens U, . Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) Core Valve ReValving System: results from the multicenter, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4(2):242–249
   PubMedGoogle Scholar
• . Tamburino C, Capodanno D, Ramondo A, . Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299–308
   PubMed Web of Science ®Google Scholar
• . Godino C, Maisano F, Montorfano M, . Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and Core Valve devices in a single center: the Milan experience. JACC Cardiovasc Interv. 2010;3(11):1110–1121
   PubMed Web of Science ®Google Scholar
• . Tay EL, Gurvitch R, Wijesinghe N, . A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4(12):1290–1297
   PubMed Web of Science ®Google Scholar
• . Zahn R, Gerckens U, Grube E, . Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32(2):198–204
   PubMed Web of Science ®Google Scholar
• . Eltchaninoff H, Prat A, Gilard M, . Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National Core Valve and Edwards) registry. Eur Heart J. 2011;32(2):191–197
   PubMed Web of Science ®Google Scholar
• . Gilard M, Eltchaninoff H, lung B, . Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705–1715
   PubMed Web of Science ®Google Scholar
• . www.ClinicalTrials.gov. Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI (AUREA). NCT01642134. http://clinicaltrials.gov/ct2/show/NCT01642134?term=duoplavin&rank=1. Accessed January 3, 2013
   Google Scholar